Azithromycin treatment is able to control the infection by two genotypes of Toxoplasma gondii in human trophoblast BeWo cells.

[1]  D. Modi,et al.  Decidual Control of Trophoblast Invasion , 2016, American journal of reproductive immunology.

[2]  N. M. Silva,et al.  Phenotypic and genotypic characterization of two Toxoplasma gondii isolates in free-range chickens from Uberlândia, Brazil , 2016, Epidemiology and Infection.

[3]  M. Baldissera,et al.  Effects of sulfamethoxazole-trimethoprim associated to resveratrol on its free form and complexed with 2-hydroxypropyl-β-cyclodextrin on cytokines levels of mice infected by Toxoplasma gondii. , 2015, Microbial pathogenesis.

[4]  M. Roque-Barreira,et al.  IL10, TGF Beta1, and IFN Gamma Modulate Intracellular Signaling Pathways and Cytokine Production to Control Toxoplasma gondii Infection in BeWo Trophoblast Cells1 , 2015, Biology of reproduction.

[5]  E. Ferro,et al.  Experimental infection of Calomys callosus with atypical strains of Toxoplasma gondii shows gender differences in severity of infection , 2014, Parasitology Research.

[6]  D. Ferguson,et al.  Congenital toxoplasmosis: continued parasite proliferation in the fetal brain despite maternal immunological control in other tissues. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  C. Su,et al.  Genetic Characterization of Toxoplasma gondii Revealed Highly Diverse Genotypes for Isolates from Newborns with Congenital Toxoplasmosis in Southeastern Brazil , 2013, Journal of Clinical Microbiology.

[8]  C. Hunter,et al.  Immune response and immunopathology during toxoplasmosis , 2012, Seminars in Immunopathology.

[9]  Ronald Anderson,et al.  Pathogen- and Host-Directed Anti-Inflammatory Activities of Macrolide Antibiotics , 2012, Mediators of inflammation.

[10]  A. Santoni,et al.  Interplay between Human Cytomegalovirus and Intrinsic/Innate Host Responses: A Complex Bidirectional Relationship , 2012, Mediators of inflammation.

[11]  P. Deloron,et al.  Congenital parasitic infections: a review. , 2012, Acta tropica.

[12]  A. Teixeira-Carvalho,et al.  Azithromycin and spiramycin induce anti-inflammatory response in human trophoblastic (BeWo) cells infected by Toxoplasma gondii but are able to control infection. , 2011, Placenta.

[13]  A. Kaye.  Toxoplasmosis: diagnosis, treatment, and prevention in congenitally exposed infants. , 2011, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.

[14]  Reed Pifer,et al.  Innate responses to Toxoplasma gondii in mice and humans. , 2011, Trends in parasitology.

[15]  L. C. Singh,et al.  Azithromycin treatment modulates the extracellular signal-regulated kinase mediated pathway and inhibits inflammatory cytokines and chemokines in epithelial cells from infertile women with recurrent Chlamydia trachomatis infection. , 2011, DNA and cell biology.

[16]  E. Ferro,et al.  Azithromycin inhibits vertical transmission of Toxoplasma gondii in Calomys callosus (Rodentia: Cricetidae). , 2009, Placenta.

[17]  J. Ajioka,et al.  Genetic diversity of Toxoplasma gondii in animals and humans , 2009, Philosophical Transactions of the Royal Society B: Biological Sciences.

[18]  N. M. Silva,et al.  Apoptosis and S phase of the cell cycle in BeWo trophoblastic and HeLa cells are differentially modulated by Toxoplasma gondii strain types. , 2009, Placenta.

[19]  Jane E Norman,et al.  Inflammation and Pregnancy , 2006, Reproductive sciences.

[20]  L. Leng,et al.  Macrophage migration inhibitory factor (MIF) is critical for the host resistance against Toxoplasma gondii , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[21]  J. Montoya,et al.  Management of Toxoplasma gondii infection during pregnancy. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  C. Su,et al.  Population structure and mouse-virulence of Toxoplasma gondii in Brazil. , 2008, International journal for parasitology.

[23]  E. Ferro,et al.  BeWo trophoblast cell susceptibility to Toxoplasma gondii is increased by interferon‐γ, interleukin‐10 and transforming growth factor‐β1 , 2008, Clinical and experimental immunology.

[24]  F. Derouin,et al.  In Vitro Susceptibility of Various Genotypic Strains of Toxoplasma gondii to Pyrimethamine, Sulfadiazine, and Atovaquone , 2008, Antimicrobial Agents and Chemotherapy.

[25]  J. Boothroyd,et al.  Differences among the three major strains of Toxoplasma gondii and their specific interactions with the infected host. , 2005, Trends in parasitology.